期刊文献+

肾癌免疫治疗进展

The progress of the immune therapy of renal cell carcinoma
原文传递
导出
摘要 肾癌细胞特殊的生物学特性使大多数肾癌对化疗和放疗不敏感,随着基因技术、肿瘤免疫、分子生物技术的迅速发展,免疫治疗成为较有前景的一种方法。应用免疫细胞、肿瘤疫苗、免疫基因等方法治疗肾癌已取得了很大的进展。现综述肾癌尤其是晚期肾癌在免疫治疗方面的进展。 The renal cell carcinoma(RCC) is not sensitive to chemotherapy and radiotherapy. Along with the rapid progress of genetic technology, tumor immunity and molecular biology technology, the immune therapy including immune cell, tumor vaccine and immune gene progresses greatly, and has a promising prospect. This article will review the progress of immune therapy in renal carcinoma.
作者 张骁 杜传军
出处 《国际肿瘤学杂志》 CAS 2006年第7期533-536,共4页 Journal of International Oncology
关键词 肾肿瘤 抗肿瘤和免疫抑制药 免疫疗法 Renal cell carcinoma Immune therapy
  • 相关文献

参考文献25

  • 1Negrier S,Maral J,Drevon M,et al.Long-term follow-up of patients with metastic renal cell carcinoma treated with intravenous recombinant IL-2 in Europe.Cancer J Sci Am,2000,2(6 Suppl 1)S93-98.
  • 2Bukowski RM.Cytokine combinations:therapeutic use in patients with advanced renal cell carcinoma.Semin Oncol,2000,27 (2):204-212.
  • 3Atzpodien J,Kirchner H,Illiger HJ,et al.IL-2 in combination with IFN-alpha and 5-FU verse tamoxifen in metastatic renal cell carcinoma:long-term result of a controlled randomised clinical trial.Br J Cancer,2001,85 (8):1130-1136.
  • 4Gez E,Rubinov R,Gaitini D,et al.Interleukin-2,interferon-alpha,5-fluorouracil,and vinblastine in the treatment of metastatic renal cell carcinoma:a prospective phase 2 study:the experience of Rambam and Lin Medical Centers,1996-2000.Cancer,2002,95 (8):1644-1649.
  • 5邱建宏.大剂量免疫化疗预防肾癌复发和转移的临床研究[J].中华泌尿外科杂志,2004,25(5):303-305. 被引量:9
  • 6McDermott DF,Regan MM,Clark JI,et al.Randomized phase Ⅲ trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma.J Clin Oncol,2005,23(1):133-141.
  • 7Coppin C,Porzsolt F,Awa A,et al.Immunotherapy for advanced renal cell cancer.Cochrane Database Syst Rev,2005,(1):CD001425.
  • 8Hernberg M,Virkkunen P,Bono P,et al.Interferon alfa-2b three times daily and thalidomide in the treatment of metastatic renal cell carcinoma.J Clin Oncol,2003,21(20):3770-3776.
  • 9May M,Helke C,Bock M,et al.Impact of immunochemotherapy on survival of patients with metastatic renal cell carcinoma.Aretrospective study comparing interferon-alpha-2a/vinblastine versusinterferon-alpha-2a/interleukin-2/5-fluorouracil.Urologe A,2004,43 (9):1111-1119.
  • 10Kuenen BC,Tabernero J,Baselga J,et al Efficacy and toxicity of the angiogenesis inhibitor SU5416 as a single agent in patients with advanced renal cell carcinoma,melanoma,and soft tissue sarcoma.Clin Cancer Res,2003,9 (5):1648-1655.

二级参考文献8

  • 1Bukowski RM.Cytokine combinations:therapeutic use in patients with advanced renal cell carcinoma.Semin Oncol,2000,27:204-212.
  • 2Roger E,Bredin H,Butler M,et al.Combined subcutaneous recombinant alpha-interferon and interleukin-2 in metastatic renal cell carcinoma:results of the Multicentre All Ireland Immunotherapy Study Group.Eur Urol,2000,37:261-266.
  • 3Belldegrun A,de Kernion JB.Renal tumors.In:Walsh PC,Retik AB,Vaughan ED,et al.eds.Campbell's urology.Vol 3.7th ed.Philadelphia:Saunders,2001.2307.
  • 4Atzpodien J,Kirchner H,Illiger HJ,et al.IL-2 in combination with IFN-alpha and 5-FU verse tamoxifen in metastatic renal cell carcinoma:long-term results of a controlled randomized clinical trial.Br J Cancer,2001,85:1130-1136.
  • 5Gez E,Rubinov R,Gaitini D,et al.Interleukin-2,interferon-alpha,5-fluorouracil,and vinblastine in the treatment of metastatic renal cell carcinoma:a prospective phase II study:the experience of Rambam and Lin Medical Centers,1996-2000.Cancer,2002,95:1644-1
  • 6Neri B,Doni L,Gemelli MT,et al.Phase II trail of weekly intravenous gemcitabine administration with interferon interleukin-2 immunotherapy for metastatic renal cell carcinoma.J Urol,2002,163:956-958.
  • 7Allen MJ,Vaughan M,Webb A,et al.Protracted venous infusion 5-fluorouracil in combination with subcutaneous interleukin-2 and alpha-interferon in patients with metastatic renal cell carcinoma:a phase II study.Br J Cancer,2000,83:980-985.
  • 8吴国英,靳风烁,江军,李黔生,李彦锋.153例肾癌术后生物化疗的临床分析[J].临床泌尿外科杂志,2003,18(1):8-9. 被引量:2

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部